Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-56,700
Closed -$2.25M 80
2018
Q2
$2.25M Buy
56,700
+6,000
+12% +$231K 0.05% 50
2018
Q1
$1.89M Buy
+50,700
New +$2.05M 0.04% 54
2017
Q3
Sell
-4,700
Closed -$213K 67
2017
Q2
$213K Sell
4,700
-25,500
-84% -$1.13M ﹤0.01% 68
2017
Q1
$1.28M Buy
30,200
+800
+3% +$32.6K 0.03% 68
2016
Q4
$1.18M Hold
29,400
0.02% 70
2016
Q3
$1.14M Hold
29,400
0.03% 66
2016
Q2
$1.02M Buy
29,400
+8,500
+41% +$294K 0.02% 65
2016
Q1
$721K Buy
20,900
+6,000
+40% +$209K 0.02% 70
2015
Q4
$576K Sell
14,900
-200
-1% -$7.78K 0.01% 72
2015
Q3
$591K Sell
15,100
-5,500
-27% -$218K 0.01% 70
2015
Q2
$784K Sell
20,600
-22,600
-52% -$791K 0.01% 71
2015
Q1
$1.43M Sell
43,200
-8,100
-16% -$249K 0.02% 57
2014
Q4
$1.37M Buy
51,300
+1,000
+2% +$25.8K 0.02% 58
2014
Q3
$1.22M Hold
50,300
0.02% 62
2014
Q2
$1.27M Buy
50,300
+6,000
+14% +$140K 0.02% 57
2014
Q1
$952K Buy
44,300
+27,000
+156% +$583K 0.01% 64
2013
Q4
$387K Buy
+17,300
New +$381K 0.01% 69

Other funds holding HOLX

Fairpointe Capital's HOLX Position: Q3 2018 in Review

Fairpointe Capital sold out of Hologic (HOLX) in Q3 2018, closing a stake of 56,700 shares — an estimated $2.25M sold.

Fairpointe Capital first reported a position in HOLX in Q4 2013 and held it in 17 quarters. The position peaked at $2.25M in Q2 2018. 446 funds tracked by Wall St. Rank hold HOLX as of Q3 2018.

  • Fairpointe Capital reported no remaining Hologic position as of Q3 2018 after selling out during the quarter.
  • Fairpointe Capital sold 56,700 Hologic shares in Q3 2018, an estimated $2.25M.
  • Fairpointe Capital first reported a position in Hologic in Q4 2013 and held it in 17 quarters.
  • Fairpointe Capital's Hologic position peaked at $2.25M in Q2 2018.
  • 446 funds tracked by Wall St. Rank held Hologic as of Q3 2018.

Based on Fairpointe Capital's 13F filing for Q3 2018, filed 15 Nov 2018.